Sana Biotechnology, Inc.

The current price of SANA is $2.34 — it has decreased by 8.59% since the previous close. Data as of Nov 5, 2026.

SANA is down 12.69% over the past week, down 18.75% over the past month and down 42.65% over the past year. The price is below its 200-day moving average of $3.36.

Analysts' average 12-month price target for SANA is $8.50, which implies 263.25% upside from the current price. Individual estimates range from $7.00 to $12.00.

Of the 9 analysts covering Sana Biotechnology, Inc., 2 rate it a strong buy, 6 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Sana Biotechnology, Inc. has a market capitalization of $700.5M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Sana Biotechnology, Inc. posted a loss of $0.22 per share against an estimate of -$0.1469, missing expectations by 49.76%. Upcoming reports are listed in the earnings calendar.

Sana Biotechnology, Inc. has not paid any dividends over the past year.

Companies most comparable to Sana Biotechnology, Inc. include CRISPR Therapeutics AG, Legend Biotech Corporation, Beam Therapeutics Inc., Intellia Therapeutics, Inc. and Cullinan Therapeutics, Inc.

In the latest trading session SANA moved between $2.28 and $2.53, a range of 10.68% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Sana Biotechnology, Inc. shows a strong sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

Over the past 52 weeks SANA has traded between $2.22 and $5.49. The current price is 57.38% below its 52-week high.